We are live on ! Find out more
BBA

BLB&B Advisors Portfolio holdings

AUM $2.73B Turnover 8.25%
1-Year Est. Return 25.76%
This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+25.76%
3 Year Est. Return
+71.58%
5 Year Est. Return
+74.54%
10 Year Est. Return
+243.21%
AUM
$462M
AUM Growth
-$5.66M
Cap. Flow
+$2.53M
Cap. Flow %
0.55%
Top 10 Hldgs %
24.77%
Holding
294
New
11
Increased
95
Reduced
121
Closed
12
Avg Time Held
1 year
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
1.1 years

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$1.65M
2
RTX icon
RTX Corp
RTX
+$1.57M
3
WDC icon
Western Digital
WDC
+$754K
4
GLW icon
Corning
GLW
+$354K
5
AMLP icon
Alerian MLP ETF
AMLP
+$322K

Sector Composition

Rank Sector Weight
1 Technology 15.51%
2 Miscellaneous 15.12%
3 Industrials 14.31%
4 Healthcare 12.24%
5 Energy 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HAWK icon
151
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$556K 0.12%
17,217
-983
-5% -$27.7K
2014 Q2
1 quarter
CVEO icon
152
Civeo
CVEO
$311M
$546K 0.12%
3,920
+1,310
+50% +$394K
2014 Q2
1 quarter
WTS icon
153
Watts Water Technologies
WTS
$11.8B
$545K 0.12%
9,354
-250
-3% -$15.3K
2014 Q1
2 quarters
ACN icon
154
Accenture
ACN
$132B
$542K 0.12%
6,661
-530
-7% -$42.5K
2014 Q1
2 quarters
CI icon
155
Cigna
CI
$76.5B
$541K 0.12%
5,968
+886
+17% +$82.8K
2013 Q2
5 quarters
TRV icon
156
Travelers Companies
TRV
$78.8B
$533K 0.12%
5,677
-121
-2% -$11.3K
2013 Q2
5 quarters
NVS icon
157
Novartis
NVS
$279B
$529K 0.11%
6,278
-825
-12% -$66.7K
2013 Q2
5 quarters
PCL icon
158
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$527K 0.11%
13,502
– –
2013 Q2
5 quarters
GAS
159
DELISTED
AGL Resources Inc
GAS
$526K 0.11%
10,248
– –
2013 Q2
5 quarters
TT icon
160
Trane Technologies
TT
$104B
$522K 0.11%
9,270
-197
-2% -$11.9K
2013 Q2
5 quarters
MFA icon
161
MFA Financial
MFA
$662M
$510K 0.11%
16,395
+3,165
+24% +$104K
2013 Q2
5 quarters
AGNC icon
162
AGNC Investment
AGNC
$10.2B
$504K 0.11%
23,705
-5,820
-20% -$134K
2013 Q2
5 quarters
WMT icon
163
Walmart Inc
WMT
$922B
$502K 0.11%
19,683
-615
-3% -$15.5K
2013 Q2
5 quarters
XLE icon
164
State Street Energy Select Sector SPDR ETF
XLE
$43.5B
$498K 0.11%
10,986
– –
2013 Q2
5 quarters
YUM icon
165
Yum! Brands
YUM
$40B
$494K 0.11%
9,552
+56
+0.6% +$2.98K
2013 Q2
5 quarters
MCK icon
166
McKesson
MCK
$114B
$493K 0.11%
2,533
-155
-6% -$29.8K
2014 Q2
1 quarter
GT icon
167
Goodyear
GT
$1.26B
$483K 0.1%
21,365
+1,200
+6% +$30.8K
2013 Q2
5 quarters
CL icon
168
Colgate-Palmolive
CL
$74B
$482K 0.1%
7,394
+2,400
+48% +$158K
2013 Q2
5 quarters
LLY icon
169
Eli Lilly
LLY
$1.08T
$482K 0.1%
7,430
+1,075
+17% +$68.1K
2013 Q2
5 quarters
XLF icon
170
State Street Financial Select Sector SPDR ETF
XLF
$50.7B
$478K 0.1%
23,513
-57
-0.2% -$1.15K
2013 Q2
5 quarters
HAL icon
171
Halliburton
HAL
$27.4B
$475K 0.1%
7,360
-200
-3% -$13.7K
2013 Q2
5 quarters
SO icon
172
Southern Company
SO
$103B
$474K 0.1%
10,866
+1,310
+14% +$57.5K
2013 Q2
5 quarters
AEGN
173
DELISTED
Aegion Corp
AEGN
$473K 0.1%
21,275
– –
2014 Q1
2 quarters
NWL icon
174
Newell Brands
NWL
$2.33B
$470K 0.1%
13,652
-325
-2% -$10.7K
2013 Q2
5 quarters
BRKR icon
175
Bruker
BRKR
$8.47B
$464K 0.1%
25,058
-400
-2% -$8.55K
2014 Q1
2 quarters

Similar funds

BLB&B Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, BLB&B Advisors held 294 positions worth $462M, down 1.2% from $468M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

BLB&B Advisors's Q3 2014 filing shows 11 new, 95 increased, 121 reduced and 12 closed positions. Its largest new stake was Magnachip Semiconductor: 37,370 shares worth $437K. The largest sale was Ionis Pharmaceuticals, an estimated $1.65M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Miscellaneous and Industrials.

  • BLB&B Advisors's largest Q3 2014 buy was Magnachip Semiconductor: 37,370 shares worth $437K.
  • BLB&B Advisors added most to Vanguard FTSE Emerging Markets ETF in Q3 2014, an estimated $1.11M increase.
  • BLB&B Advisors's biggest Q3 2014 reduction was Ionis Pharmaceuticals, cutting an estimated $1.65M.
  • BLB&B Advisors fully exited Alerian MLP ETF in Q3 2014, selling an estimated $322K.
  • BLB&B Advisors's ten largest holdings make up 25% of its $462M portfolio in Q3 2014.
  • BLB&B Advisors opened 11 new positions and closed 12 in Q3 2014.
  • BLB&B Advisors's portfolio value fell 1.2% quarter-over-quarter to $462M.

Based on BLB&B Advisors's 13F filing for Q3 2014, filed 21 Oct 2014.